Pierre Labbé

Pierre Labbé appears in our data through filings on Immunovaccine Inc. shares, published by SEDI. Between 13 February 2017 and 12 February 2018, the trades on record add up to 15 filings.

The open-market record is one-sided, with 13 purchases worth €149k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 option exercise. So far in 2018, the count stands at 2 purchases and no sales.

Half of the purchases are above €8,443 and half below. The 13 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The latest filing, published on 13 February 2018, reports an open-market purchase of €25k in Immunovaccine Inc. The median gap between trade and publication is zero days: most filings appear on the same day. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.